JPH0359905B2 - - Google Patents

Info

Publication number
JPH0359905B2
JPH0359905B2 JP20602282A JP20602282A JPH0359905B2 JP H0359905 B2 JPH0359905 B2 JP H0359905B2 JP 20602282 A JP20602282 A JP 20602282A JP 20602282 A JP20602282 A JP 20602282A JP H0359905 B2 JPH0359905 B2 JP H0359905B2
Authority
JP
Japan
Prior art keywords
general formula
formula
mentioned meaning
represented
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP20602282A
Other languages
Japanese (ja)
Other versions
JPS5998076A (en
Inventor
Masatoshi Ban
Kenji Hamase
Tomoo Suzuki
Hiromoto Kimura
Tadashi Terada
Masatsune Kurono
Hiroyoshi Hidaka
Nobuyuki Ito
Shuji Ando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Priority to JP20602282A priority Critical patent/JPS5998076A/en
Publication of JPS5998076A publication Critical patent/JPS5998076A/en
Publication of JPH0359905B2 publication Critical patent/JPH0359905B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発明は新規なシドノンイミン化合物又はその
酸付加塩及びこれらの製法に係る。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel sydnonimine compounds or acid addition salts thereof and methods for producing them.

本発明による新規なシドノンイミン化合物は一
般式 (式中R1はモルホピロリジノ、モルホピペリ
ジノ又はβ−ニコチノイルアミノエチル基を意味
し、R2は水素又はカルボエトキシ基を意味する)
にて示される。
The novel sydnonimine compounds according to the present invention have the general formula (In the formula, R 1 means morphopyrrolidino, morphopiperidino or β-nicotinoylaminoethyl group, and R 2 means hydrogen or carboethoxy group)
It is shown in

一般式にて示される本発明による化合物は血
管拡張作用を有しており、従つて血圧降下剤又は
抗狭心剤として有用である。
The compounds according to the invention of the general formula have vasodilatory action and are therefore useful as antihypertensive or antianginal agents.

本発明方法によれば、一般式にて示される化
合物及びその酸付加塩は、ホルムアルデヒド及び
シアン化合物を一般式 R1−NH2 () (式中R1はモルホピロリジノ、モルホピペリ
ジノ又はβ−ニコチノイルアミノエチル基を意味
する)にて示されるアミンと反応させ、得たる一
般式 R1−NH−CH2CN () (式中R1は前記の意味を有する)にて示され
るアミノニトリルを鉱酸媒体中で亜硝酸ナトリウ
ムにより処理し、得たる一般式 (式中R1は前記の意味を有する)にて示され
るニトロソアミノニトリルを鉱酸で処理して環化
し、得たる一般式 (式中R1は前記の意味を有する)にて示され
る化合物を必要に応じ酸付加塩に変じるか、又は
一般式 XCOOC2H5 () (式中Xはハロゲン原子を意味する)にて示さ
れるハロ蟻酸エチルエステルにて処理し、得たる
一般式 (式中R1は前記の意味を有する)にて示され
る化合物を必要に応じ酸付加塩に変ずることによ
り得ることができる。
According to the method of the present invention, the compound represented by the general formula and its acid addition salt can be prepared by combining formaldehyde and a cyanide compound with the general formula R 1 -NH 2 () (wherein R 1 is morphopyrrolidino, morphopiperidino or β-nicotinoylamino). An amino nitrile represented by the general formula R 1 -NH-CH 2 CN () (in which R 1 has the above-mentioned meaning) is reacted with an amine represented by Treatment with sodium nitrite in medium gives the general formula (In the formula, R 1 has the above-mentioned meaning) is treated with a mineral acid to cyclize the nitrosoaminonitrile, resulting in the general formula If necessary, the compound represented by the formula The general formula obtained by treatment with haloformic acid ethyl ester shown in It can be obtained by converting the compound represented by the formula (in which R 1 has the above-mentioned meaning) into an acid addition salt, if necessary.

本発明方法に使用されるシアン化物としてはシ
アン化水素又はシアン化カリウムが適当である。
酸付加塩を形成するための酸としては、生成する
塩が薬理学的に認容し得るものであれば良く、例
えば塩酸、臭化水素酸、燐酸等の無機酸や、マレ
イン酸、フマル酸、酒石酸、蓚酸、メタンスルホ
ン酸等の有機酸を挙げることができる。
Suitable cyanides used in the process of the invention are hydrogen cyanide or potassium cyanide.
The acid for forming the acid addition salt may be any acid as long as the resulting salt is pharmacologically acceptable, such as inorganic acids such as hydrochloric acid, hydrobromic acid, phosphoric acid, maleic acid, fumaric acid, etc. Organic acids such as tartaric acid, oxalic acid, and methanesulfonic acid can be mentioned.

尚、一般式にて示される化合物及びその酸付
加塩は結晶化又はクロマトグラフ吸着処理により
精製することができる。
The compound represented by the general formula and its acid addition salt can be purified by crystallization or chromatographic adsorption treatment.

例 1 3−(β−ニコチノイルアミノエチル)シドノ
ンイミン・2塩酸塩 水55ml中に、N−ニコチノイルエチレンジアミ
ン14.2g(86ミリモル)と、ホルムアルデヒド・亜
硫酸水素ナトリウム・1水和物13.2g(86.6ミリモ
ル)とを添加して1時間撹拌し、次いでシアン化
カリウム5.6g(86ミリモル)を添加して50〜55℃
で3時間に亘り撹拌した。反応混合物は冷却し
て、上部の油層を除去し、残液を酢酸エチル抽出
した。この抽出物を無水硫酸ナトリウムで乾燥さ
せ、濃縮し、シリカゲルカラム処理すれば(溶出
液:酢酸エチル/メタノール)、N−シアノメチ
ル−N′−ニコチノイルエチレンジアミン8.63g(収
率49.1%)が得られる。
Example 1 3-(β-nicotinoylaminoethyl)cydononeimine dihydrochloride 14.2 g (86 mmol) of N-nicotinoylethylenediamine and 13.2 g (86.6 mmol) of formaldehyde sodium bisulfite monohydrate were added to 55 ml of water, stirred for 1 hour, and then 5.6 g (86 mmol) of potassium cyanide was added. mmol) at 50-55℃
The mixture was stirred for 3 hours. The reaction mixture was cooled, the upper oil layer was removed, and the residual liquid was extracted with ethyl acetate. If this extract is dried over anhydrous sodium sulfate, concentrated, and treated with a silica gel column (eluent: ethyl acetate/methanol), 8.63 g of N-cyanomethyl-N'-nicotinoylethylenediamine (yield 49.1%) is obtained. .

次いで、水5.6ml中に上記ジアミン4.63g(22.7ミ
リモル)と濃塩酸2.3mlとを溶解させ、次いで冷
却して2〜3℃に保ち撹拌した。水2.3mlに亜硝
酸ナトリウム1.57g(22.7ミリモル)を溶解した溶
酸を上記撹拌溶液に滴下し、次いで全体を0℃で
1時間に亘り撹拌した。析出結晶を取し、乾燥
し、塩化メチレン/エーテルで再結晶させれば融
点105〜106.5℃のN−シアノメチル−N−ニトロ
ソ−N′−ニコチノイルエチレンジアミン2.80g(収
率52.9%)が得られる。
Next, 4.63 g (22.7 mmol) of the above diamine and 2.3 ml of concentrated hydrochloric acid were dissolved in 5.6 ml of water, then cooled, kept at 2 to 3° C., and stirred. A solution of 1.57 g (22.7 mmol) of sodium nitrite dissolved in 2.3 ml of water was added dropwise to the stirred solution, and the whole was then stirred at 0° C. for 1 hour. If the precipitated crystals are collected, dried, and recrystallized from methylene chloride/ether, 2.80 g (yield 52.9%) of N-cyanomethyl-N-nitroso-N'-nicotinoylethylenediamine with a melting point of 105-106.5°C is obtained. .

得られたこのニトリル2.5g(10.7ミリモル)に
塩酸/メタノール溶液を滴下して1時間放置した
後に濃縮し、エタノール/エーテル溶液で再結晶
させれば、所望の3−(β−ニコチノイルアミノ
エチル)シドノンイミン・2塩酸塩1.0g(収率
30.3%)が得られる。
A hydrochloric acid/methanol solution is added dropwise to 2.5 g (10.7 mmol) of the obtained nitrile, left for 1 hour, concentrated, and recrystallized from an ethanol/ether solution to obtain the desired 3-(β-nicotinoylaminoethyl). ) Sidononeimine dihydrochloride 1.0g (yield
30.3%).

融点 171〜174℃(分解) 元素分析: 理論値 C39.23 H4.28 N22.88 実測値 C39.01 H4.28 N22.78 MS : (CI/DI)m/e;234(M+1−HCl)+,203 (EI/DI)m/e;234,203,176,135,106 IR(KBr):1680(=NH),1670(C=0)cm-1 例 2 3−(N−モルホピロリジノ)シドノンイミ
ン・1塩酸塩・1水和物 水45ml中に、N−アミノモルホピロリジン
24.8g(0.194モル)と、ホルムアルデヒド・亜硫
酸水素ナトリウム、1水和物29.5g(0.194モル)
とを添加して室温で1時間撹拌した。不溶物を
去し、シアン化カリウム12.6g(0.194モル)を添
加し、55℃で3時間撹拌した後に冷却して酢酸エ
チル抽出した。抽出物を無水硫酸ナトリウムで乾
燥し、濃縮し、減圧蒸留すれば、沸点99〜106
℃/0.2mmHgのN−シアノメチルアミノモルホピ
ロリジン21.5g(収率66.4%)が得られる。
Melting point 171-174℃ (decomposition) Elemental analysis: Theoretical value C39.23 H4.28 N22.88 Actual value C39.01 H4.28 N22.78 MS: (CI/DI) m/e; 234 (M+1-HCl) + , 203 (EI/DI) m/e; 234, 203, 176, 135, 106 IR (KBr): 1680 (=NH), 1670 (C=0) cm -1 Example 2 3-(N-morphopyrrolidino) Sidononeimine monohydrochloride monohydrate N-aminomorphopyrrolidine in 45 ml of water.
24.8g (0.194mol) and formaldehyde/sodium bisulfite, monohydrate 29.5g (0.194mol)
and stirred at room temperature for 1 hour. Insoluble matter was removed, 12.6 g (0.194 mol) of potassium cyanide was added, and the mixture was stirred at 55°C for 3 hours, cooled, and extracted with ethyl acetate. If the extract is dried over anhydrous sodium sulfate, concentrated, and distilled under reduced pressure, the boiling point is 99-106.
21.5 g (66.4% yield) of N-cyanomethylaminomorphopyrrolidine with a temperature of 0.2 mmHg is obtained.

このモルホピロリジンの塩酸塩9.5g(0.0467モ
ル)を水40mlに溶解し、水5mlに亜硝酸ナトリウ
ム3.54g(0.0514モル)を溶解した溶液を0℃で且
つアルゴン気流化に滴下した。この滴下後1時間
撹拌した後に、生成した黄色結晶を取し、冷水
で洗浄すれば、N−(N−シアノメチル−N−ニ
トロソアミノ)モルホピロリジン6.5g(収率71.0
%)が得られる。
9.5 g (0.0467 mol) of this morphopyrrolidine hydrochloride was dissolved in 40 ml of water, and a solution of 3.54 g (0.0514 mol) of sodium nitrite dissolved in 5 ml of water was added dropwise at 0° C. under an argon atmosphere. After stirring for 1 hour after this dropwise addition, the yellow crystals formed were collected and washed with cold water to yield 6.5 g of N-(N-cyanomethyl-N-nitrosamino)morphopyrrolidine (yield 71.0).
%) is obtained.

得られたこのニトリル6.5g(0.0332モル)をメ
タノール50mlに溶解させ、3N−塩酸性メタノー
ル溶液31mlを滴下して1時間撹拌した後にエーテ
ルを滴下して結晶化させれば、所望の3−(N−
モルホピロリジノ)シドノンイミン・1塩酸塩・
1水和物6.2g(収率74.5%)が得られる。
By dissolving 6.5 g (0.0332 mol) of the obtained nitrile in 50 ml of methanol, adding 31 ml of 3N-hydrochloric methanol solution dropwise and stirring for 1 hour, adding ether dropwise to crystallize, the desired 3-( N-
morphopyrrolidino) sydnonimine monohydrochloride
6.2 g (yield 74.5%) of monohydrate are obtained.

融点 145〜147℃ 元素分析: 理論値 C38.33 H6.03 N22.35 実測値 C38.33 H5.95 N22.42 MS : (CI/DI)m/e;168(M−28)+,166(M−
30)+ (EI/DI)m/e;196(M)+ IR(KBr);3450,3050,1680,1140,885cm-1 例 3 3−(N−モルホピペリジノ)シドノンイミ
ン・1塩酸塩 水32.5ml中に、N−アミノモルホピペリジン
17.1g(0.12モル)と、ホルムアルデヒド・亜硫酸
水素ナトリウム・1水和物18.3g(0.12モル)とを
添加して室温で1時間撹拌した。次いで不溶物を
去し、シアン化カリウム7.83g(0.12モル)を添
加し、50〜55℃で3時間撹拌した後に一夜放置す
る。析出結晶を取し、水洗すればN−シアノメ
チルアミノモルホピペリジン13.0g(収率59.9%)
が得られる。
Melting point 145-147℃ Elemental analysis: Theoretical value C38.33 H6.03 N22.35 Actual value C38.33 H5.95 N22.42 MS: (CI/DI) m/e; 168 (M-28) + , 166 (M-
30) + (EI/DI) m/e; 196 (M) + IR (KBr); 3450, 3050, 1680, 1140, 885 cm -1 example 3 3-(N-morphopiperidino) sydonone imine monohydrochloride N-aminomorphopiperidine in 32.5 ml of water.
17.1 g (0.12 mol) and 18.3 g (0.12 mol) of formaldehyde sodium bisulfite monohydrate were added and stirred at room temperature for 1 hour. Next, insoluble materials were removed, 7.83 g (0.12 mol) of potassium cyanide was added, and the mixture was stirred at 50 to 55°C for 3 hours and left overnight. Take the precipitated crystals and wash them with water to obtain 13.0 g of N-cyanomethylaminomorphopiperidine (yield 59.9%)
is obtained.

このモルホピペリジン4.6g(0.0211モル)を水
20mlに溶解させ、水2mlに亜硝酸ナトリウム1.6g
(0.0233モル)を溶解した溶液を0℃で且つアル
ゴン気流下に滴下した。この滴下後1時間撹拌し
た後に、析出結晶を取し、冷水で洗浄すれば、
N−(N−シアノメチル−N−ニトロソアミノ)
モルホピペリジン4.3g(収率97.0%)が得られる。
Add 4.6g (0.0211mol) of this morphopiperidine to water.
1.6g of sodium nitrite dissolved in 20ml of water
(0.0233 mol) was added dropwise at 0° C. under an argon stream. After stirring for 1 hour after this dropwise addition, the precipitated crystals are collected and washed with cold water.
N-(N-cyanomethyl-N-nitrosamino)
4.3 g of morphopiperidine (yield 97.0%) is obtained.

このニトリル4.3g(0.0205モル)を塩酸性メタ
ノール溶液で処理し、エチルエーテルで結晶化さ
せれば、所望の3−(N−モルホピペリジノシド
ノンイミン・1塩酸塩4.9g(収率97.0%)が得ら
れる。
If 4.3 g (0.0205 mol) of this nitrile is treated with a methanol solution of hydrochloric acid and crystallized with ethyl ether, 4.9 g (yield 97.0 %) is obtained.

融点142〜145℃ 元素分析: 理論値 C43.82 H6.13 N22.71 実測値 C43.71 H6.11 N22.33 MS : (CI/DI)m/e;182(M−28)+,180(M−
30) (EI/DI)m/e;210(M)+ IR(KBr):3450,3075,1685,1080cm-1 例 4 3−モルホピロリジノ−N−カルボエトキシシ
ドノンイミン 例2に記載の方法により得たるシドノンイミン
化合物3.3g(0.0132モル)を乾燥ピリジン16mlに
溶解させ、この溶液に0℃でクロル蟻酸エチルエ
ステル5.3g(0.0488モル)を滴下し、次いで室温
で一夜撹拌した。析出固体を去し、液を濃縮
し、エタノールを添加した後に再び濃縮した。こ
れをシリカゲルカラム処理し(溶出液:塩化メチ
レン)、塩化メチレン/エーテルで再結晶化すれ
ば、所望の3−モルホピロリジノ−N−カルボエ
トキシシドノンイミン2.4g(収率67.8%)が得ら
れる。
Melting point 142-145℃ Elemental analysis: Theoretical value C43.82 H6.13 N22.71 Actual value C43.71 H6.11 N22.33 MS: (CI/DI) m/e; 182 (M-28) + , 180 (M-
30) (EI/DI) m/e; 210 (M) + IR (KBr): 3450, 3075, 1685, 1080 cm -1 example 4 3-morphopyrrolidino-N-carboethoxysydnonimine 3.3 g (0.0132 mol) of the sydnonimine compound obtained by the method described in Example 2 was dissolved in 16 ml of dry pyridine, and 5.3 g (0.0488 mol) of ethyl chloroformate was added dropwise to this solution at 0°C, followed by stirring overnight at room temperature. did. The precipitated solid was removed, the liquid was concentrated, and after adding ethanol, it was concentrated again. This is treated with a silica gel column (eluent: methylene chloride) and recrystallized from methylene chloride/ether to obtain 2.4 g (yield: 67.8%) of the desired 3-morphopyrrolidino-N-carboethoxysydnonimine.

融点 90〜91℃ 元素分析: 理論値 C49.25 H6.01 N20.88 実測値 C49.26 H6.06 N20.88 MS : (CI/DI)m/e;269(M+1)+ (EI/DI)m/e;268(M)+,238(M−30)+
194(M−74)+ IR(KBr):3135,1660(C=O),1585,1268,
1074(C−O−C),968cm-1 例 5 3−モルホピペリジノ−N−カルボエトキシシ
ドノンイミン 例3に記載の方法により得たるシドノンイミン
化合物3.0g(0.0122モル)を乾燥ピリジン15mlに
溶解させ、この溶液に0℃でクロル蟻酸エチルエ
ステル4.5g(0.0415モル)を滴下し、次いで例4
に記載の処理を同様にして行なえば、所望の3−
モルホピペリジノ−N−カルボエトキシシドノン
イミン2.0g(収率58.1%)が得られる。
Melting point 90-91℃ Elemental analysis: Theoretical value C49.25 H6.01 N20.88 Actual value C49.26 H6.06 N20.88 MS: (CI/DI) m/e; 269 (M+1) + (EI/DI ) m/e; 268 (M) + , 238 (M-30) + ,
194 (M-74) + IR (KBr): 3135, 1660 (C=O), 1585, 1268,
1074 (C-O-C), 968 cm -1 Example 5 3-morphopiperidino-N-carboethoxysidononimine 3.0 g (0.0122 mol) of the sydnonimine compound obtained by the method described in Example 3 was dissolved in 15 ml of dry pyridine, 4.5 g (0.0415 mol) of ethyl chloroformate was added dropwise to this solution at 0°C, and then 4.5 g (0.0415 mol) of chloroformic acid ethyl ester was added dropwise to this solution at 0°C.
If the process described in 2 is performed in the same way, the desired 3-
2.0 g (yield 58.1%) of morphopiperidino-N-carboethoxysydnonimine is obtained.

融点 111〜111.5℃ 元素分析: 理論値 C51.06 H6.43 N19.85 実測値 C50.97 H6.59 N19.87 MS : (CI/DI)m/e;283(M+1)+ (EI/DI)m/e;282(M)+,252(M−30)+
208(M−74)+ IR(KBr):3145(シドノンC−H),3000(C−
H),1650(C=O),1570(N−COO),1270,
1080(C−O−C)cm-1
Melting point 111-111.5℃ Elemental analysis: Theoretical value C51.06 H6.43 N19.85 Actual value C50.97 H6.59 N19.87 MS: (CI/DI) m/e; 283 (M+1) + (EI/DI ) m/e; 282 (M) + , 252 (M-30) + ,
208 (M-74) + IR (KBr): 3145 (Sydonone C-H), 3000 (C-
H), 1650 (C=O), 1570 (N-COO), 1270,
1080(C-O-C)cm -1

Claims (1)

【特許請求の範囲】 1 一般式 (式中R1はモルホピロリジノ、モルホピペリ
ジノ又はβ−ニコチノイルアミノエチル基を意味
し、R2は水素又はカルボエトキシ基を意味する)
にて示される新規なシドノンイミン化合物又はそ
の酸付加塩。 2 ホルムアルデヒド及びシアン化合物を一般式 R1−NH2 () (式中R1はモルホピロリジノ、モルホピペリ
ジノ又はβ−ニコチノイルアミノエチル基を意味
する)にて示されるアミンと反応させ、得たる一
般式 R1−NH−CH2CN () (式中R1は前記の意味を有する)にて示され
るアミノニトリルを鉱酸媒体中で亜硝酸ナトリウ
ムにより処理し、得たる一般式 (式中R1は前記の意味を有する)にて示され
るニトロソアミノニトリルを鉱酸で処理して環化
し且つ必要に応じ酸付加塩に変ずることを特徴と
する、 一般式 (式中R1は前記の意味を有する)にて示され
る新規なシドノンイミン化合物又はその酸付加塩
の製法。 3 ホルムアルデヒド及びシアン化合物を一般式 R1−NH2 () (式中R1はモルホピロリジノ、モルホピペリ
ジノ又はβ−ニコチノイルアミノエチル基を意味
する)にて示されるアミンと反応させ、得たる一
般式 R1−NH−CH2CN () (式中R1は前記の意味を有する)にて示され
るアミノニトリルを鉱酸媒体中で亜硝酸ナトリウ
ムにより処理し、得たる一般式 (式中R1は前記の意味を有する)にて示され
るニトロソアミノニトリルを鉱酸で処理して環化
し、得たる一般式 (式中R1は前記の意味を有する)にて示され
る化合物を一般式 XCOOC2H5 () (式中Xはハロゲン原子を意味する)にて示さ
れるハロ蟻酸エステルと反応させ且つ必要に応じ
酸付加塩に変ずることを特徴とする、一般式 (式中R1は前記の意味を有する)にて示され
る新規なシドノンイミン化合物又はその酸付加塩
の製法。
[Claims] 1. General formula (In the formula, R 1 means morphopyrrolidino, morphopiperidino or β-nicotinoylaminoethyl group, and R 2 means hydrogen or carboethoxy group)
A novel sydnonimine compound or an acid addition salt thereof shown in 2 Formaldehyde and a cyanide compound are reacted with an amine represented by the general formula R 1 -NH 2 (in the formula, R 1 means morphopyrrolidino, morphopiperidino or β-nicotinoylaminoethyl group) to obtain the general formula R The general formula obtained by treating aminonitrile represented by 1 -NH-CH 2 CN () (in which R 1 has the above-mentioned meaning) with sodium nitrite in a mineral acid medium (wherein R 1 has the above-mentioned meaning) is treated with a mineral acid to cyclize the nitrosoaminonitrile and, if necessary, convert it into an acid addition salt. A method for producing a novel sydnonimine compound or an acid addition salt thereof represented by the formula (wherein R 1 has the above-mentioned meaning). 3 Formaldehyde and a cyanide compound are reacted with an amine represented by the general formula R 1 -NH 2 (in the formula, R 1 means morphopyrrolidino, morphopiperidino or β-nicotinoylaminoethyl group) to obtain the general formula R The general formula obtained by treating aminonitrile represented by 1 -NH-CH 2 CN () (in which R 1 has the above-mentioned meaning) with sodium nitrite in a mineral acid medium (In the formula, R 1 has the above-mentioned meaning) is treated with a mineral acid to cyclize the nitrosoaminonitrile, resulting in the general formula (in the formula, R 1 has the above-mentioned meaning) is reacted with a haloformic acid ester represented by the general formula XCOOC 2 H 5 () (in the formula, X means a halogen atom), and A general formula characterized by the ability to transform into acid addition salts depending on A method for producing a novel sydnonimine compound or an acid addition salt thereof represented by the formula (wherein R 1 has the above-mentioned meaning).
JP20602282A 1982-11-26 1982-11-26 Novel sydnoneimine compound and its preparation Granted JPS5998076A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20602282A JPS5998076A (en) 1982-11-26 1982-11-26 Novel sydnoneimine compound and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20602282A JPS5998076A (en) 1982-11-26 1982-11-26 Novel sydnoneimine compound and its preparation

Publications (2)

Publication Number Publication Date
JPS5998076A JPS5998076A (en) 1984-06-06
JPH0359905B2 true JPH0359905B2 (en) 1991-09-12

Family

ID=16516599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20602282A Granted JPS5998076A (en) 1982-11-26 1982-11-26 Novel sydnoneimine compound and its preparation

Country Status (1)

Country Link
JP (1) JPS5998076A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3820210A1 (en) * 1988-06-14 1989-12-21 Cassella Ag SUBSTITUTED 3-AMINO-DYNONOMINES, PROCESS FOR THEIR PREPARATION AND THEIR USE

Also Published As

Publication number Publication date
JPS5998076A (en) 1984-06-06

Similar Documents

Publication Publication Date Title
US10730876B2 (en) Synthesis of a compound that modulates kinases
JP3179515B2 (en) Method for producing 2-chlorothiazoles
JP6832946B2 (en) How to prepare kinase inhibitors and their intermediates
JPS626718B2 (en)
NO328627B1 (en) Process for the preparation of iopamidol and the novel intermediates therein
KR920002295B1 (en) Process for the preparation of pyrrolidone derivatives
JP3712619B2 (en) Catechol hydrazone derivative, production method and pharmaceutical composition containing the same
JPH0359905B2 (en)
JP3759411B2 (en) 4-Cyano-3-hydroxybutanoylhydrazines, derivatives thereof and method for producing the same
JP2771257B2 (en) Preparation of imidazole derivatives
JP2767295B2 (en) Method for producing indole-3-carbonitrile compound
WO2001044165A1 (en) Processes for producing (aminomethyl)trifluorocarbinol derivatives
SU1531854A3 (en) Method of obtaining ranitidin or its hydrochloride
JP4425366B2 (en) Process for producing N-benzyl-3-hydroxyazetidine
KR100361824B1 (en) Process for preparing 2-aminothiazol carboxamide derivatives useful in killing plant pathogenic bacteria
SU471711A3 (en) Method for producing α-aminoacrylic acid derivatives
JP2001261647A5 (en)
JP2671401B2 (en) .ALPHA.-Aminothioacetamide derivative and its production method
JP3216673B2 (en) Method for producing 3-hydroxyisoxazole
JP3127505B2 (en) Method for producing pyrazolopyridine derivative
KR800001549B1 (en) Preparing process for thiayolyl acetate
JP2563864B2 (en) Method for producing 2- (3,4-dimethoxystyryl) -3,1-benzoxazin-4-one
JPS6317869A (en) Production of 2-lower alkyl-4-amino-5-formylpyrimidine
WO2019098551A1 (en) Method for preparing intermediate compound for synthesizing pharmaceutical
CN110878045A (en) Compound and preparation method and application thereof